. Author manuscript; available in PMC: 2022 Jan 5.

Published in final edited form as: Matern Child Health J. 2016 Nov;20(11):2372–2381. doi: 10.1007/s10995-016-2064-3

Table 2.

Generalized linear regression models predicting elevated depressive symptoms (≥13 on modified CES-D) over time among partners from pregnancy through 1 year postpartum

	OR (95 % CI)
	Females (n = 220)	Males (n = 189)
Main effects^a
Time	0.70 (0.55, 0.89)^**	0.96 (0.74, 1.26)
Individual
Age at baseline (actor)	0.74 (0.64, 0.86)^**
Social support (actor)	0.95 (0.93, 0.97)^**	0.97 (0.95, 1.00)^*
Any marijuana use (past 3 months; actor)		1.82 (1.04, 3.20)^*
Dyad
Relationship satisfaction (actor)	0.97 (0.96, 0.98)^**	0.98 (0.96, 0.99)^**
Relationship satisfaction (partner)	0.99 (0.98, 1.00)^*
Family support of relationship (actor)		0.92 (0.87, 0.97)^**
Family support of relationship (partner)		0.93 (0.88, 0.98)^*
Effects over time^b
Individual
Any cigarette use (past 3 months; actor)		0.50 (0.27, 0.90)^*
Dyad
IPV from father/mother of the baby (actor)	0.56 (0.31, 1.00)^*	0.49 (0.25, 0.94)^*
Elevated depressive symptoms (partner)	0.40 (0.23, 0.69)^**

^**

p value <0.01;

p value <0.05

The main effects model for young females includes time, age, social support, and relationship satisfaction for both her and her partner. The main effects model for young males includes time, social support, marijuana use, relationship satisfaction, his and his partner’s family support of the relationship

The effects over time (e.g., IPV*time and partner depressive symptoms*time for females) were modeled independent of one another by including the interaction term with its main effect (e.g., IPV and partner depressive symptoms, respectively, for females) into the corresponding main effect model presented above